First malaria vaccine for babies tested in groundbreaking safety trial
NCT ID NCT06618885
Summary
This study is testing a new malaria vaccine called SUM-101 in young children and infants for the first time. It aims to find out if the vaccine is safe, what side effects it might cause, and if it produces a good immune response against malaria. The study involves 69 healthy children aged 5 months to 5 years in Burkina Faso, who will receive three doses of either the test vaccine or a control vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Groupe de Recherche Action en Santé (GRAS)
Ouagadougou, 06 BP 10248, Burkina Faso
Conditions
Explore the condition pages connected to this study.